Cutler Group’s Celldex Therapeutics CLDX Stock Holding History

Cutler Group’s Portfolio CLDX Stock Details CLDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-19,600	Closed	-$4K	–	2439
2023 Q4	$4K	Buy	19,600 +16,900	+626%	+$497K	﹤0.01%	2805
2023 Q3	$16K	Sell	2,700 -400	-13%	-$12.5K	﹤0.01%	2182
2023 Q2	$22K	Buy	3,100 +1,000	+48%	+$33.7K	﹤0.01%	1794
2023 Q1	$16K	Sell	2,100 -5,100	-71%	-$220K	﹤0.01%	2029
2022 Q4	$3K	Sell	7,200 -100	-1%	-$3.57K	﹤0.01%	3442
2022 Q3	$22K	Buy	7,300 +3,400	+87%	+$104K	﹤0.01%	2535
2022 Q2	$66K	Buy	3,900 +500	+15%	+$14.5K	﹤0.01%	1733
2022 Q1	$59K	Sell	3,400 -3,700	-52%	-$118K	﹤0.01%	2113
2021 Q4	$12K	Buy	+7,100	New	+$309K	﹤0.01%	3525
2017 Q3	–	Sell	-20	Closed	-$2K	–	5937
2017 Q2	$2K	Hold	20	–	–	﹤0.01%	5451
2017 Q1	$1K	Hold	20	–	–	﹤0.01%	5764
2016 Q4	$1K	Hold	20	–	–	﹤0.01%	5914
2016 Q3	$1K	Sell	20 -67	-77%	-$4.17K	﹤0.01%	6046
2016 Q2	$12K	Sell	87 -1,506	-95%	-$95.6K	﹤0.01%	3915
2016 Q1	$381K	Sell	1,593 -1,194	-43%	-$134K	0.03%	643
2015 Q4	$211K	Buy	+2,787	New	+$608K	0.01%	1149

Other funds holding CLDX

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return